Cocaethylene Formation Following Ethanol and Cocaine Administration by Different Routes

Experimental and Clinical Psychopharmacology

Volumn 19, Issue 2, 2011, Pages 95-104

  Herbst, Ellen D ^a   Harris, Debra S ^b   Everhart, E Thomas ^a   Mendelson, John ^c   Jacob, Peyton ^a   Jones, Reese T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Alcohol; Cocaethylene; Cocaine; First pass metabolism; Routes of administration

Indexed keywords

ALCOHOL; BENZOYLECGONINE; COCAINE; HOMOCOCAINE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; FIRST PASS EFFECT; GAS CHROMATOGRAPHY; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MASS SPECTROMETRY; METABOLISM; ORAL DRUG ADMINISTRATION; PLASMA; SMOKING; URINE;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BEHAVIOR; BLOOD PRESSURE; COCAINE; DRUG INTERACTIONS; ETHANOL; FEMALE; HALF-LIFE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PLACEBOS; SMOKING;

EID: 79954559552     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0022950     Document Type: Article

References (43)

1. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Author, Washington, DC. 4th ed.
2. Barrett S.P., Darredeau C., Pihl R.O. Patterns of simultaneous polysubstance use in drug using university students. Human Psychopharmacology: Clinical and Experimental 2006, 21:255-263.
3. Brzezinski M.R., Abraham T.L., Stone C.L., Dean R.A., Bosron W.F. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochemical Pharmacology 1994, 48:1747-1755.
4. Brzezinski M.R., Spink B.J., Dean R.A., Berkman C.E., Cashman J.R., Bosron W.F. Human liver carboxylesterase hCE-1: Binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metabolism and Disposition 1997, 25:1089-1096.
5. Cone E.J. Pharmacokinetics and pharmacodynamics of cocaine. Journal of Analytical Toxicology 1995, 19:459-478.
6. Cook C.E. Pyrolytic characteristics, pharmacokinetics, and bioavailability of smoked heroin, cocaine, phencyclidine, and methamphetamine. National Institute on Drug Abuse Research Monograph 1991, 115:6-23.
7. Cook C.E., Jeffcoat A.R. Pyrolytic degradation of heroin, phencyclidine, and cocaine: Identification of products and some observations on their metabolism. National Institute on Drug Abuse Research Monograph 1990, 99:97-120.
8. Cook C.E., Jeffcoat A.R., Hill J.M., Pugh D.E., Patetta P.K., Sadler B.M., Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)methamphetamine hydrochloride. Drug Metabolism and Disposition 1993, 21:717-723.
9. Cregler L.L., Mark H. Medical complications of cocaine abuse. New England Journal of Medicine 1986, 315:1438-1443.
10. Dean R.A., Christian C.D., Sample R.H.B., Bosron W.F. Human liver cocaine esterases: Ethanol-mediated formation of ethylcocaine. Federation of the American Societies for Experimental Biology Journal 1991, 5:2735-2739.
11. Dean R.A., Harper E.T., Dumaual N., Stoeckel D.A., Bosron W.F. Effects of ethanol on cocaine metabolism: Formation of cocaethylene and norcocaethylene. Toxicology and Applied Pharmacology 1992, 117:1-8.
12. Everhart E.T., Jacob P., Mendelson J., Jones R.T. The synthesis of deuterium-labelled cocaine, cocaethylene and its metabolites. Journal of Labelled Compounds and Radiopharmaceuticals 1999, 42:1265-1275.
13. Farooq M.U., Bhatt A., Patel M. Neurotoxic and cardiotoxic effects of cocaine and ethanol. Journal of Medical Toxicology 2009, 5:134-138.
14. Farre M., De La Torre R., Gonzalez M.L., Teran M.T., Roset P.N., Menoyo E., Camí J. Cocaine and alcohol interactions in humans: Neuroendocrine effects and cocaethylene metabolism. Journal of Pharmacology and Experimental Therapeutics 1997, 274:215-223.
15. Farre M., De La Torre R., Llorente M., Lamas X., Ugena B., Segura J., Camí J. Alcohol and cocaine interactions in humans. Journal of Pharmacology and Experimental Therapeutics 1993, 266:1364-1373.
16. Fattinger K., Benowitz N.L., Jones R.T., Verotta D. Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine. European Journal of Clinical Pharmacology 2000, 56:305-310.
17. Foltin R.W., Fischman M.W. Ethanol and cocaine interactions in humans: Cardiovascular consequences. Pharmacology Biochemistry and Behavior 1988, 31:877-883.
18. Gibaldi M., Perrier D. Pharmacokinetics 1982, Marcel Dekker, New York, NY. 2nd ed.
19. Gossop M., Manning V., Ridge G. Concurrent use and order of use of cocaine and alcohol: Behavioural differences between users of crack cocaine and cocaine powder. Addiction 2006, 101:1292-1298.
20. Grant B., Harford T. Concurrent and simultaneous use of alcohol with cocaine: Results of a national survey. Drug and Alcohol Dependence 1990, 25:97-104.
21. Harris D.S., Everhart E.T., Mendelson J., Jones R.T. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug and Alcohol Dependence 2003, 72:169-182.
22. Hart C.L., Jatlow P., Sevarino K.A., McCance-Katz E.F. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology 2000, 149:153-162.
23. Hearn W.L., Flynn D.D., Hime G.W., Rose S., Cofino J.C., Mantero-Atienza E., Mash D.C. Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. Journal of Neurochemistry 1991, 56:98-701.
24. Hedden S., Martins S., Malcolm R., Floyd L., Cavanaugh C., Latimer W. Patterns of illegal drug use among an adult alcohol dependent population: Results from the National Survey on Drug Use and Health. Drug and Alcohol Dependence 2010, 106:119-125.
25. Henning R.J., Wilson L.D. Cocaethylene is as cardiotoxic as cocaine but is less toxic than cocaine plus ethanol. Life Sciences 1996, 59:615-627.
26. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Badger G.J. Alcohol dependence and simultaneous cocaine and alcohol use in cocaine-dependent patients. Journal of Addictive Diseases 1994, 13:177-189.
27. Higgins S.T., Rush C.R., Bickel W.K., Hughes J.R., Lynn M., Capeless M.A. Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans. Psychopharmacology 1993, 111:285-294.
28. Hime G.W., Hearn W.L., Rose S., Cofino J. Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry. Journal of Analytical Toxicology 1991, 15:241-245.
29. Inaba T., Stewart D.J., Kalow W. Metabolism: Clinical and experimental of cocaine in man. Clinical Pharmacology and Therapeutics 1978, 23:547-552.
30. Jacob P., Elias-Baker B.A., Jones R.T., Benowitz N.L. Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. Journal of Chromatography 1987, 417:277-286.
31. Jeffcoat A.R., Perez-Reyes M., Hill J.M., Sadler B.M., Cook C.E. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metabolism and Disposition 1989, 17:153-159.
32. McCance E.F., Price L.H., Kosten T.R., Jatlow P.I. Cocaethylene: Pharmacology, physiology, and behavioral effects in humans. Journal of Pharmacology and Experimental Therapeutics 1995, 274:215-223.
33. McCance E.F., Price L.H., McDougle C.J., Kosten T.R., Black J.E., Jatlow P.I. Concurrent cocaine-ethanol ingestion in humans: Pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology 1993, 111:39-46.
34. McCance-Katz E.F., Kosten T.R., Jatlow P.I. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone-A multiple dose study. Biological Psychiatry 1998, 44:250-259.
35. Mendelson J.H., McGuire J., Mello N.K. A new device for delivering placebo alcohol. Alcohol 1984, 1:417-419.
36. Pan W.J., Hedaya M.A. Cocaine and alcohol interactions in the rat: Contribution of cocaine metabolites to the pharmacological effects. Journal of Pharmaceutical Sciences 1999, 88:468-476.
37. Parker R.B., Laizure S.C. The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions. Drug Metabolism and Disposition 2010, 38:317-322.
38. Patel M.B., Opreanu M., Shah A.J., Pandya K., Bhadula R., Abela G.S., Thakur R.K. Cocaine and alcohol: A potential lethal duo. The American Journal of Medicine 2009, 122:5-6.
39. Perez-Reyes M., Jeffcoat A.R. Ethanol/cocaine interaction: Cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sciences 1992, 51:553-563.
40. Rose S., Hearn W.L., Hime G.W., Wetli C.V., Ruttenber A.J., Mash D.S. Cocaine and cocaethylene concentrations in human post mortem cerebral cortex [Abstract]. Society for Neuroscience Abstracts 1990, 16:14.
41. Signs S.A., Dickey-White H.I., Vanek V.W., Perch S., Schechter M.D., Kulics A.T. The formation of cocaethylene and clinical presentation of ED patients testing positive for the use of cocaine and ethanol. American Journal of Emergency Medicine 1996, 14:665-670.
42. Van Dyke C.S. Cocaine increases natural killer cell activity. Journal of Clinical Investigation 1986, 77:1387-1390.
43. Wiener S.E., Sutijono D., Moon C.H., Subramanian R.A., Calaycay J., Rushbrook J.I., Zehtabchi S. Patients with detectable cocaethylene are more likely to require intensive care unit admission after trauma. American Journal of Emergency Medicine 2010, 28:1051-1055.